Tumor counts were recorded each week and mice were sacrificed at multiple time points (6 hours, 3, 7, 10, and 30 weeks of treatment), for subsequent analysis of B-Raf/Mek/Erk pathway signaling. The gene discussed is MAP2K7; the disease is neoplasm.